Clinical Trial Update: Preoperative Oral Magnesium to Prevent Postoperative Atrial Fibrillation Following Coronary Surgery (POMAF-CS) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating preoperative oral magnesium to prevent postoperative atrial fibrillation after coronary surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Coronary Artery Disease

Snippet

Sponsor: St Joseph University, Beirut, Lebanon | Conditions: Atrial Fibrillation, Coronary Artery Disease | Phase 4 | Status: COMPLETED